GO-4C8

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGO-4C8

Drug Alias NameGO-4C8

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesGo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A